Exploring the role of cannabis in medicine, politics, history, and society, The Pot Bookoffers a compendium of the most up-to-date information and scientific research on marijuana from leading experts, including Lester Grinspoon, M.D., Rick Doblin, Ph.D., Allen St. Pierre (NORML), and Raphael Mechoulam. Also included are interviews with Michael Pollan, Andrew Weil, M.D., and Tommy Chong as well as a pot dealer and a farmer who grows for the U.S. Government. Encompassing the broad spectrum of marijuana knowledge from stoner customs to scientific research, this book investigates the top ten myths of marijuana; its physiological and psychological effects; its risks; why joints are better than water pipes and other harm-reduction tips for users; how humanity and cannabis have co-evolved for millennia; the brain’s cannabis-based neurochemistry; the complex politics of cannabis law; its potential medicinal uses for cancer, AIDS, Alzheimer’s, multiple sclerosis, and other illnesses; its role in creativity, business, and spirituality; and the complicated world of pot and parenting. As legalization becomes a reality, this book candidly offers necessary facts and authoritative opinions in a society full of marijuana myths, misconceptions, and stereotypes.
Inhaltsverzeichnis
Foreword by Lester Grinspoon, M.D.
Introduction
Part One
An Overview of Cannabis
Introduction to Part One
1 The Subjective Effects of Cannabis
Matthew G. Kirkpatrick and Carl L. Hart, Ph.D.
2 Early/Ancient History
Chris Bennett
3 Recent History
David Malmo-Levine
4 The Botany of Cannabis
Lyle E. Craker, Ph.D., and Zoë Gardner
5 Cannabis Grow Revolution
Danny Danko
6 The Endocannabinoid System
Gregory L. Gerdeman, Ph.D., and Jason B. Schechter, Ph.D.
7 Anandamide and More
Raphael Mechoulam, Ph.D., and Lumír Hanuš
8 Cannabis Laws in the United States
Allen St. Pierre
9 On Ending Prohibition
Ethan Nadelmann, J.D., Ph.D.
Part Two
Risks of Use and Harm Reduction
Introduction to Part Two
10 Medical Risks and Toxicology
William Holubek, M.D.
11 Pulmonary Harm and Vaporizers
Mitch Earleywine, Ph.D.
12 Cannabis and Cognition
Caroline B. Marvin and Carl L. Hart, Ph.D.
13 Mental Health Risks Associated with Cannabis Use
Cheryl Corcoran, M.D.
14 How Real Is the Risk of Addiction?
Ryan Vandrey, Ph.D., and Margaret Haney, Ph.D.
15 Driving Under the Influence
Paul Armentano
16 Arrest Statistics and Racism
Harry G. Levine, Ph.D.
17 Getting Busted Is Not So Funny
An Interview with Tommy Chong
Julie Holland, M.D.
18 The Collateral Consequences of Cannabis Convictions
Richard Glen Boire, J.D.
19 Harm Reduction Psychotherapy
Andrew Tatarsky, Ph.D.
Part Three
The Clinical Use of Cannabis
Introduction to Part Three
20 The Clinical Applications of Medical Marijuana
An Interview with Andrew Weil, M.D.
Julie Holland, M.D.
21 Medical Marijuana Research
An Interview with Donald Abrams, M.D.
Julie Holland, M.D.
22 MAPS and the Federal Obstruction of
Medical Marijuana Research
Rick Doblin, Ph.D.
23 The Government’s Pot Farm
An Interview with Mahmoud A. ElSohly, Ph.D.
Julie Holland, M.D.
24 Cannabinoids and Psychiatry
Julie Holland, M.D.
25 Cannabinoids and Neuroprotection
Sunil K. Aggarwal, M.D., Ph.D., and Gregory T. Carter, M.D.
26 Cannabis and HIV/AIDS
Mark A. Ware, M.D., and Lynne Belle-Isle
27 Multiple Sclerosis and Spasticity
Denis J. Petro, M.D.
28 Pain Management
Mark S. Wallace, M.D., and Ben Platt, M.D.
29 Sativex
William Notcutt, M.D., F.R.C.A., F.F.P.M.R.C.A.
Part Four
Cannabis Culture
Introduction to Part Four
30 What to Tell the Children
Marsha Rosenbaum, Ph.D.
31 Pot, Parenting, and Outing Myself
Neal Pollack
32 Cannabis: Stealth Goddess
Doug Rushkoff
33 Gardener’s Rights, Forgetting, and Co-Evolution
An Interview with Michael Pollan
Julie Holland, M.D.
34 Cannabis, Business, and Philanthropy
An Interview with Peter Lewis
Julie Holland, M.D.
35 Thots on Pot
Jeremy Wolff
Part Five
Steps in the Right Direction
Introduction to Part Five
36 Patients Out of Time
An Interview with Al Byrne, L.CDR. (retired), and Mary Lynn Mathre, R.N., C.A.R.N.
Julie Holland, M.D.
37 Prescribing Cannabis in California
Jeffrey Hergenrather, M.D.
38 Canadian Compassion Clubs
N. Rielle Capler, M.H.A.
39 Dutch Drug Policy
Mario Lap
40 A Cost-Benefit Analysis of Legalizing Marijuana
Jeffrey Miron, Ph.D.
41 The Marijuana Policy Project
Bruce Mirken
42 The ACLU and Cannabis Drug Policy
An Interview with Graham Boyd, J.D.
Julie Holland, M.D.
Resources
References
Contributors
Index